Merck Gains FDA Approval for First OTC Patch for Overactive Bladder

The FDA has approved Merck's (NYSE: MRK  ) Oxytrol for Women, the first over-the-counter treatment for overactive bladder in women, a condition that Merck says affects more than 20 million American women.

Overactive bladder is characterized by a strong urge to urinate right away and the need to urinate more often. It typically affects women between the ages of 45 and 60.

Oxytrol was previously a prescription-only patch, but Merck convinced the FDA that it was safe enough for over-the-counter status. The company ran a series of studies to prove that women could correctly diagnose that they have overactive bladder and that they could use the patch correctly unsupervised.

Merck licensed Oxytrol as an over-the-counter treatment for overactive bladder from Watson Pharmaceuticals, now known as Actavis (NYSE: ACT  ) . Oxytrol will remain as a prescription drug for the treatment of overactive bladder in men.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2216603, ~/Articles/ArticleHandler.aspx, 4/17/2014 5:43:42 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

TREND TRACKER: Get Rich When the Web Goes Dark

It's time to say "goodbye" to your Internet! One bleeding-edge technology is about to put the World Wide Web to bed. And if you act right away, it could make you wildly rich. Experts are calling it the single largest business opportunity in the history of capitalism… The Economist is calling it "transformative"... but you'll probably just call it "how I made my millions." Big money is already on the move. Don't be too late to the party – find out the 1 stock to own when the Web goes dark.